Department of Neurology, Union Hospital-Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Division of Pediatric Surgery, Department of Surgery, Children's Research Institute-Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
FASEB J. 2019 Apr;33(4):4947-4961. doi: 10.1096/fj.201801706RR. Epub 2019 Jan 17.
Angiogenesis is a crucial defense response to hypoxia that regulates the process of raising the promise of long-term neurologic recovery during the management of stroke. A high expression of antiangiogenic factors leads to the loss of neovascularization capacity in pathologic conditions. We have previously documented an impairment of the cerebral vessel perfusion and neovascularization in the cortex neighboring the stroke-induced lesion, which was accompanied by an activation of semaphorin 3E (Sema3E)/PlexinD1 after ischemic stroke. In this study, we employed micro-optical sectioning tomography to fully investigate the details of the vascular pattern, including the capillaries. We found that after transient middle cerebral artery occlusion, inhibiting PlexinD1 signaling led to an organized recovery of the vascular network in the ischemic area. We then further explored the possible mechanisms. In vivo, Sema3E substantially decreased dynamic delta-like 4 (DLL4) expression. In cultured brain microvascular endothelial cells, Sema3E down-regulated DLL4 expression via inhibiting Ras-related C3 botulinum toxin substrate 1-induced JNK phosphorylation. At the microcosmic level, Sema3E/PlexinD1 signaling promoted F-actin disassembly and focal adhesion reduction by activating the small guanosine triphosphatase Ras homolog family member J by releasing RhoGEF Tuba from direct binding to PlexinD1, thus mediating endothelial cell motility and filopodia retraction. Our study reveals that Sema3E/PlexinD1 signaling, which suppressed endothelial DLL4 expression, cell motility, and filopodia formation, is expected to be a novel druggable target for angiogenesis during poststroke progression.-Zhou, Y.-F., Chen, A.-Q., Wu, J.-H., Mao, L., Xia, Y.-P., Jin, H.-J., He, Q.-W., Miao, Q. R., Yue, Z.-Y., Liu, X.-L., Huang, M., Li, Y.-N., Hu, B. Sema3E/PlexinD1 signaling inhibits postischemic angiogenesis by regulating endothelial DLL4 and filopodia formation in a rat model of ischemic stroke.
血管生成是对缺氧的关键防御反应,调节脑卒中管理过程中长期神经恢复的过程。抗血管生成因子的高表达导致病理性新生血管能力丧失。我们之前记录了脑卒中诱导损伤附近皮质的脑血管灌注和新生血管受损,这伴随着缺血性脑卒中后 Sema3E(Semaphorin 3E)/PlexinD1 的激活。在这项研究中,我们采用微光学切片断层扫描来全面研究血管模式的细节,包括毛细血管。我们发现,短暂性大脑中动脉闭塞后,抑制 PlexinD1 信号导致缺血区血管网络的有序恢复。然后我们进一步探索了可能的机制。在体内,Sema3E 大量减少了动态 Delta-like 4(DLL4)的表达。在培养的脑微血管内皮细胞中,Sema3E 通过抑制 Ras 相关 C3 肉毒杆菌毒素底物 1 诱导的 JNK 磷酸化来下调 DLL4 的表达。在微观水平上,Sema3E/PlexinD1 信号通过从小 GTP 酶 Ras 同源家族成员 J 释放 RhoGEF Tuba 来激活 Ras 相关 C3 肉毒杆菌毒素底物 1 诱导的 JNK 磷酸化,从而促进 F-肌动蛋白解聚和焦点粘连减少,从而介导内皮细胞的迁移和丝状伪足回缩。我们的研究表明,Sema3E/PlexinD1 信号通过抑制内皮 DLL4 表达、细胞迁移和丝状伪足形成来抑制血管生成,有望成为脑卒中后进展过程中血管生成的新的可药物治疗靶点。